SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
快乐再出发
Lv3
340 积分
2022-08-22 加入
最近求助
最近应助
互助留言
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial
10天前
已完结
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
10天前
已完结
Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapy
13天前
已完结
Pseudoprogression in lung cancer patients treated with immunotherapy
25天前
已完结
Tessellated fundus occurs earlier than myopia in children aged 3–6 years
1个月前
已关闭
Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population
1个月前
已完结
Clinical features and survival of lung cancer patients with pleural effusions
1个月前
已完结
Features of post-obstructive pneumonia in advanced lung cancer patients, a large retrospective cohort
1个月前
已完结
Radiotherapy as metastasis-directed therapy for oligometastatic prostate cancer
1个月前
已完结
The oligometastatic spectrum in the era of improved detection and modern systemic therapy
1个月前
已完结
没有进行任何应助
感谢
10天前
感谢
10天前
感谢
13天前
暂时不需要了【积分已退回】
1个月前
感谢
1个月前
感谢
1个月前
感谢
1个月前
感谢
1个月前
感谢
1个月前
感谢
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论